Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Lorlatinib

1

I.a Pneumonitis (ILD), acute and/or severe (may cause ARDS)

1
Last update : 18/02/2020
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Post-marketing safety of lorlatinib: a real-world study based on the FDA adverse event reporting system.
Frontiers in pharmacology 2024;15;1385036 2024
An Unusual Case of Lorlatinib-Induced Pneumonitis: A Case Report.
Case reports in oncology 2022;15;225-230 2022
Lorlatinib-Associated Acute Respiratory Distress Syndrome.
American journal of therapeutics 2020;27;e698-e699 2020

Powered by

  • ^
  • Contact
  • Cookies
  • About